{
    "filename": "19-1351.pdf",
    "content_type": "application/pdf",
    "file_size": 842073,
    "metadata": {
        "identifiers": {
            "doi": "10.3201/eid2602.191351",
            "url": "https://wwwnc.cdc.gov/eid/article/26/2/pdfs/19-1351.pdf"
        },
        "date": 2020,
        "title": "Rapid Nanopore Whole-Genome Sequencing for Anthrax Emergency Preparedness",
        "author": "Heather P. McLaughlin, Julia V. Bugrysheva, Andrew B. Conley, Christopher A. Gulvik, Blake Cherney, Cari B. Kolton, Chung K. Marston, Elke Saile, Erin Swaney, David Lonsway, Amy S. Gargis, Thiphasone Kongphet-Tran, Christine Lascols, Pierre Michel, Julie Villanueva, Alex R. Hoffmaster, Jay E. Gee, David Sue",
        "affiliations": [
            "Laboratory antimicrobial susceptibility testing (AST) by broth microdilution (BMD)",
            "Tech Applied Bioinformatics Laboratory, Atlanta (A.B. Conley); Texas Department of State Health Services Laboratory, Austin, Texas, USA (E. Swaney)"
        ],
        "journal": "Emerging Infectious Diseases",
        "volume": "26",
        "abstract": "Human anthrax cases necessitate rapid response. We completed Bacillus anthracis nanopore whole-genome sequencing in our high-containment laboratory from a human anthrax isolate hours after receipt. The de novo assembled genome showed no evidence of known antimicrobial resistance genes or introduced plasmid(s). Same-day genomic characterization enhances public health emergency response.",
        "references": "@article{carlson2019a,\n  author = {Carlson, C.J. and Kracalik, I.T. and Ross, N. and Alexander, K.A. and Hugh-Jones, M.E. and Fegan, M.},\n  title = {The global distribution of Bacillus anthracis and associated anthrax risk to humans, livestock and wildlife},\n  journal = {Nat Microbiol},\n  date = {2019},\n  volume = {4},\n  pages = {1337\u201343},\n  more-authors = {true},\n  language = {}\n}\n@misc{hendricks2014a,\n  author = {Hendricks, K.A. and Wright, M.E. and Shadomy, S.V. and Bradley, J.S. and Morrow, M.G. and Pavia, A.T.},\n  title = {Workgroup on Anthrax Clinical Guidelines. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis},\n  date = {2014},\n  volume = {20},\n  pages = {130687},\n  url = {https://doi.org/10.3201/eid2002.130687},\n  more-authors = {true},\n  language = {}\n}\n@article{price2003a,\n  author = {Price, L.B. and Vogler, A. and Pearson, T. and Busch, J.D. and Schupp, J.M. and Keim, P.},\n  title = {In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin},\n  journal = {Antimicrob Agents Chemother},\n  date = {2003},\n  volume = {47},\n  pages = {2362\u20135},\n  url = {https://doi.org/10.1128/AAC.47.7.2362-2365.2003},\n  language = {}\n}\n@book{pomerantsev1992a,\n  author = {Pomerantsev, A.P. and Shishkova, N.A. and Marinin, L.I.},\n  title = {Comparison of therapeutic effects of antibiotics of the tetracycline group in the treatment of anthrax caused by a strain inheriting tet-gene of plasmid pBC16},\n  publisher = {Antibiot Khimioter},\n  date = {1992},\n  volume = {37},\n  pages = {31\u20134},\n  language = {},\n  address = {in Russian}\n}\n@article{ross2009a,\n  author = {Ross, C.L. and Thomason, K.S. and Koehler, T.M.},\n  title = {An extracytoplasmic function sigma factor controls beta-lactamase gene expression in Bacillus anthracis and other Bacillus cereus group species},\n  journal = {J Bacteriol},\n  date = {2009},\n  volume = {191},\n  pages = {6683\u201393},\n  language = {}\n}\n@article{weigel2010a,\n  author = {Weigel, L.M. and Sue, D. and Michel, P.A. and Kitchel, B. and Pillai, S.P.},\n  title = {A rapid antimicrobial susceptibility test for Bacillus anthracis},\n  journal = {Antimicrob Agents Chemother},\n  date = {2010},\n  volume = {54},\n  pages = {2793\u2013800},\n  language = {}\n}\n@misc{gargis2018a,\n  author = {Gargis, A.S. and McLaughlin, H.P. and Conley, A.B. and Lascols, C. and Michel, P.A. and Gee, J.E.},\n  title = {Analysis of whole-genome sequences for the prediction of penicillin resistance and \u03b2-lactamase activity in Bacillus anthracis. mSystems},\n  date = {2018},\n  volume = {3},\n  pages = {00154\u201318},\n  more-authors = {true},\n  language = {}\n}\n@article{gren2014a,\n  author = {\u00c5gren, J. and Finn, M. and Bengtsson, B. and Segerman, B.},\n  title = {Microevolution during an anthrax outbreak leading to clonal heterogeneity and penicillin resistance},\n  journal = {PLoS One},\n  date = {2014},\n  volume = {9},\n  pages = {89112},\n  url = {https://doi.org/10.1371/journal.pone.0089112},\n  language = {}\n}\n@article{wick2017a,\n  author = {Wick, R.R. and Judd, L.M. and Gorrie, C.L. and Holt, K.E.},\n  title = {Completing bacterial genome assemblies with multiplex MinION sequencing},\n  journal = {Microb Genom},\n  date = {2017},\n  volume = {3},\n  pages = {000132},\n  url = {https://doi.org/10.1099/mgen.0.000132},\n  language = {}\n}\n@article{goodwin2016a,\n  author = {Goodwin, S. and McPherson, J.D. and McCombie, W.R.},\n  title = {Coming of age: ten years of next-generation sequencing technologies},\n  journal = {Nat Rev Genet},\n  date = {2016},\n  volume = {17},\n  pages = {333\u201351},\n  url = {https://doi.org/10.1038/nrg.2016.49},\n  language = {}\n}\n@article{quick2016a,\n  author = {Quick, J. and Loman, N.J. and Duraffour, S. and Simpson, J.T. and Severi, E. and Cowley, L.},\n  title = {portable genome sequencing for Ebola surveillance},\n  journal = {Nature},\n  date = {2016},\n  volume = {530},\n  pages = {228\u201332},\n  url = {https://doi.org/10.1038/nature16996},\n  more-authors = {true},\n  language = {}\n}\n@article{greninger2015a,\n  author = {Greninger, A.L. and Naccache, S.N. and Federman, S. and Yu, G. and Mbala, P. and Bres, V.},\n  title = {Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis},\n  journal = {Genome Med},\n  date = {2015},\n  volume = {7},\n  pages = {99},\n  url = {https://doi.org/10.1186/s13073-015-0220-9},\n  more-authors = {true},\n  language = {}\n}\n@article{gargis2019a,\n  author = {Gargis, A.S. and Cherney, B. and Conley, A.B. and McLaughlin, H.P. and Sue, D.},\n  title = {Rapid detection of genetic engineering, structural variation, and antimicrobial resistance markers in bacterial biothreat pathogens by nanopore sequencing},\n  journal = {Sci Rep},\n  date = {2019},\n  volume = {9},\n  pages = {13501},\n  url = {https://doi.org/10.1038/s41598-019-49700-1},\n  language = {}\n}\n@book{unknown2016a,\n  title = {Methods for antimicrobial dilution and disc susceptibility testing of infrequently isolated or fastidious bacteria},\n  edition = {3rd ed. M45},\n  publisher = {The Institute},\n  date = {2016},\n  language = {},\n  address = {Wayne (PA},\n  organization = {Clinical and Laboratory Standards Institute}\n}\n@article{nouioui2019a,\n  author = {Nouioui, I. and Klenk, H.-P. and Igual, J.M. and Gulvik, C.A. and Lasker, B.A. and McQuiston, JR},\n  title = {Streptacidiphilus bronchialis sp. nov., a ciprofloxacin-resistant bacterium from a human clinical specimen; reclassification of Streptomyces griseoplanus as Streptacidiphilus griseoplanus comb. nov. and emended description of the genus Streptacidiphilus},\n  journal = {Int J Syst Evol Microbiol},\n  date = {2019},\n  volume = {69},\n  pages = {1047\u201356},\n  url = {https://doi.org/10.1099/ijsem.0.003267},\n  language = {}\n}\n",
        "links": [
            "https://pypi.org",
            "https://nanoporetech.com",
            "https://cge",
            "https://blast.ncbi.nlm",
            "https://www.illumina.com)\u2013based",
            "http://www.cdc.gov/eid",
            "https://github.com"
        ],
        "emails": [
            "yfq4@cdc.gov"
        ],
        "pages": "358-361",
        "references_ris": "TY  - JOUR\nAU  - Carlson, C.J.\nAU  - Kracalik, I.T.\nAU  - Ross, N.\nAU  - Alexander, K.A.\nAU  - Hugh-Jones, M.E.\nAU  - Fegan, M.\nTI  - The global distribution of Bacillus anthracis and associated anthrax risk to humans, livestock and wildlife\nT2  - Nat Microbiol\nPY  - 2019\nDA  - 2019\nVL  - 4\nSP  - 1337\nEP  - 43\nC1  - true\nLA  - \nER  - \n\nTY  - GEN\nAU  - Hendricks, K.A.\nAU  - Wright, M.E.\nAU  - Shadomy, S.V.\nAU  - Bradley, J.S.\nAU  - Morrow, M.G.\nAU  - Pavia, A.T.\nTI  - Workgroup on Anthrax Clinical Guidelines. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis\nPY  - 2014\nDA  - 2014\nVL  - 20\nSP  - 130687\nUR  - https://doi.org/10.3201/eid2002.130687\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Price, L.B.\nAU  - Vogler, A.\nAU  - Pearson, T.\nAU  - Busch, J.D.\nAU  - Schupp, J.M.\nAU  - Keim, P.\nTI  - In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin\nT2  - Antimicrob Agents Chemother\nPY  - 2003\nDA  - 2003\nVL  - 47\nSP  - 2362\nEP  - 5\nUR  - https://doi.org/10.1128/AAC.47.7.2362-2365.2003\nLA  - \nER  - \n\nTY  - BOOK\nAU  - Pomerantsev, A.P.\nAU  - Shishkova, N.A.\nAU  - Marinin, L.I.\nTI  - Comparison of therapeutic effects of antibiotics of the tetracycline group in the treatment of anthrax caused by a strain inheriting tet-gene of plasmid pBC16\nPB  - Antibiot Khimioter\nPY  - 1992\nDA  - 1992\nVL  - 37\nSP  - 31\nEP  - 4\nLA  - \nCY  - in Russian\nER  - \n\nTY  - JOUR\nAU  - Ross, C.L.\nAU  - Thomason, K.S.\nAU  - Koehler, T.M.\nTI  - An extracytoplasmic function sigma factor controls beta-lactamase gene expression in Bacillus anthracis and other Bacillus cereus group species\nT2  - J Bacteriol\nPY  - 2009\nDA  - 2009\nVL  - 191\nSP  - 6683\nEP  - 93\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Weigel, L.M.\nAU  - Sue, D.\nAU  - Michel, P.A.\nAU  - Kitchel, B.\nAU  - Pillai, S.P.\nTI  - A rapid antimicrobial susceptibility test for Bacillus anthracis\nT2  - Antimicrob Agents Chemother\nPY  - 2010\nDA  - 2010\nVL  - 54\nSP  - 2793\nEP  - 800\nLA  - \nER  - \n\nTY  - GEN\nAU  - Gargis, A.S.\nAU  - McLaughlin, H.P.\nAU  - Conley, A.B.\nAU  - Lascols, C.\nAU  - Michel, P.A.\nAU  - Gee, J.E.\nTI  - Analysis of whole-genome sequences for the prediction of penicillin resistance and \u03b2-lactamase activity in Bacillus anthracis. mSystems\nPY  - 2018\nDA  - 2018\nVL  - 3\nSP  - 00154\nEP  - 18\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - \u00c5gren, J.\nAU  - Finn, M.\nAU  - Bengtsson, B.\nAU  - Segerman, B.\nTI  - Microevolution during an anthrax outbreak leading to clonal heterogeneity and penicillin resistance\nT2  - PLoS One\nPY  - 2014\nDA  - 2014\nVL  - 9\nSP  - 89112\nUR  - https://doi.org/10.1371/journal.pone.0089112\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Wick, R.R.\nAU  - Judd, L.M.\nAU  - Gorrie, C.L.\nAU  - Holt, K.E.\nTI  - Completing bacterial genome assemblies with multiplex MinION sequencing\nT2  - Microb Genom\nPY  - 2017\nDA  - 2017\nVL  - 3\nSP  - 000132\nUR  - https://doi.org/10.1099/mgen.0.000132\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Goodwin, S.\nAU  - McPherson, J.D.\nAU  - McCombie, W.R.\nTI  - Coming of age: ten years of next-generation sequencing technologies\nT2  - Nat Rev Genet\nPY  - 2016\nDA  - 2016\nVL  - 17\nSP  - 333\nEP  - 51\nUR  - https://doi.org/10.1038/nrg.2016.49\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Quick, J.\nAU  - Loman, N.J.\nAU  - Duraffour, S.\nAU  - Simpson, J.T.\nAU  - Severi, E.\nAU  - Cowley, L.\nTI  - portable genome sequencing for Ebola surveillance\nT2  - Nature\nPY  - 2016\nDA  - 2016\nVL  - 530\nSP  - 228\nEP  - 32\nUR  - https://doi.org/10.1038/nature16996\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Greninger, A.L.\nAU  - Naccache, S.N.\nAU  - Federman, S.\nAU  - Yu, G.\nAU  - Mbala, P.\nAU  - Bres, V.\nTI  - Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis\nT2  - Genome Med\nPY  - 2015\nDA  - 2015\nVL  - 7\nSP  - 99\nUR  - https://doi.org/10.1186/s13073-015-0220-9\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Gargis, A.S.\nAU  - Cherney, B.\nAU  - Conley, A.B.\nAU  - McLaughlin, H.P.\nAU  - Sue, D.\nTI  - Rapid detection of genetic engineering, structural variation, and antimicrobial resistance markers in bacterial biothreat pathogens by nanopore sequencing\nT2  - Sci Rep\nPY  - 2019\nDA  - 2019\nVL  - 9\nSP  - 13501\nUR  - https://doi.org/10.1038/s41598-019-49700-1\nLA  - \nER  - \n\nTY  - BOOK\nTI  - Methods for antimicrobial dilution and disc susceptibility testing of infrequently isolated or fastidious bacteria\nET  - 3rd ed. M45\nPB  - The Institute\nPY  - 2016\nDA  - 2016\nLA  - \nCY  - Wayne (PA\nC1  - Clinical and Laboratory Standards Institute\nER  - \n\nTY  - JOUR\nAU  - Nouioui, I.\nAU  - Klenk, H.-P.\nAU  - Igual, J.M.\nAU  - Gulvik, C.A.\nAU  - Lasker, B.A.\nAU  - McQuiston, JR\nTI  - Streptacidiphilus bronchialis sp. nov., a ciprofloxacin-resistant bacterium from a human clinical specimen; reclassification of Streptomyces griseoplanus as Streptacidiphilus griseoplanus comb. nov. and emended description of the genus Streptacidiphilus\nT2  - Int J Syst Evol Microbiol\nPY  - 2019\nDA  - 2019\nVL  - 69\nSP  - 1047\nEP  - 56\nUR  - https://doi.org/10.1099/ijsem.0.003267\nLA  - \nER  - \n\n",
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": [
            {
                "id": "1",
                "caption": "Time required to detect antimicrobial resistance markers in Bacillus anthracis strain Ba0914 by using WGS and summary of assembly results. A) Comparison of time to complete rapid nanopore (MinION) and short-read (iSeq) sequencing laboratory workflows. Workflows include DNA extraction, library preparation, WGS, and bioinformatics analysis. B) Comparison of nanopore-based and short-read sequencing\u2013 based data used to assemble the B. anthracis chromosome and plasmid sequences and to detect known AMR mutations and genes. Mutations associated with fluoroquinolone resistance in B. anthracis are located within the quinolone resistance\u2013determining regions of gyrA, gyrB, parC, and parE genes. AMR genes contained in the Resfinder database (https:// cge.cbs.dtu.dk) were queried against the assemblies. The rsiP mutation associated with penicillin resistance was not included. The nanopore assembly was generated by using the first 120,000 basecalled reads. AMR, antimicrobial resistance; WGS, whole-genome sequencing"
            },
            {
                "id": "2",
                "caption": "Circular maps of the whole-genome\u2013sequenced Bacillus anthracis Ba0914 chromosome and 2 plasmids, pXO1 and pXO2, assembled by using rapid nanopore sequencing and short-read sequencing. (Maps are not to scale.)"
            }
        ],
        "figure_urls": [
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/19-1351/img-000.png",
            "https://scholarcy.nyc3.digitaloceanspaces.com/images/docker-test/19-1351/img-001.png"
        ]
    },
    "sections": {
        "conclusions": [
            "Real-time sequencing of the biothreat pathogen B. anthracis in a high-containment laboratory demonstrated the speed and usefulness of a rapid, portable<br/><br/>Table. De novo whole-genome assembly metrics for sequencing of Bacillus anthracis strain Ba0914*<br/><br/>Nucleotide identity, %; average fold coverage    Aligned to    Mismatches    Indels    Contigs    Chromosome pXO1    pXO2<br/><br/>Ames reference strain    Nanopore"
        ],
        "acknowledgments": [
            "We thank scientists in the Zoonoses and Select Agent Laboratory, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), CDC, for performing shortread sequencing; scientists in the Antimicrobial Resistance and Characterization Laboratory, Division of Healthcare Quality Promotion, NCEZID, CDC, for performing conventional BMD AST; and scientists in the Biodefense Research and Development Laboratory, Division of Preparedness and Emerging Infections, NCEZID, CDC, for performing nanopore sequencing.<br/><br/>This study was supported by the CDC Center for Preparedness and Response.    About the Author<br/><br/>Dr. McLaughlin is a scientist at the Biodefense Research and Development Laboratory, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Her primary research interests are development and evaluation of phenotypic and whole-genome sequencing\u2013based assays to characterize biological threat agents, with an emphasis on rapid detection of antimicrobial resistance in bacteria."
        ],
        "funding": [
            "We thank scientists in the Zoonoses and Select Agent Laboratory, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), CDC, for performing shortread sequencing; scientists in the Antimicrobial Resistance and Characterization Laboratory, Division of Healthcare Quality Promotion, NCEZID, CDC, for performing conventional BMD AST; and scientists in the Biodefense Research and Development Laboratory, Division of Preparedness and Emerging Infections, NCEZID, CDC, for performing nanopore sequencing. This study was supported by the CDC Center for Preparedness and Response"
        ],
        "introduction": [
            "Human anthrax cases necessitate rapid response. We completed Bacillus anthracis nanopore whole-genome sequencing in our high-containment laboratory from a human anthrax isolate hours after receipt. The de novo assembled genome showed no evidence of known antimicrobial resistance genes or introduced plasmid(s). Same-day genomic characterization enhances public health emergency response.",
            "Bacillus anthracis causes anthrax, a deadly infectious disease, and is found worldwide, including areas of the United States. Naturally occurring anthrax outbreaks are reported annually in wild and domestic grazing animals, but human transmission is rare [<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>]. Deliberate misuse of B. anthracis as a bioweapon could pose an immediate risk to human populations. In such instances, a timely response is critical to reduce morbidity and mortality rates."
        ]
    },
    "structured_content": {
        "Conclusions": [
            "Real-time sequencing of the biothreat pathogen B. anthracis in a high-containment laboratory demonstrated the speed and usefulness of a rapid, portable",
            "Table. De novo whole-genome assembly metrics for sequencing of Bacillus anthracis strain Ba0914*"
        ],
        "Aligned to": [],
        "Ames reference strain": [],
        "SRS assembly": [
            "nanopore sequencer during an emergency. Longread sequencing could detect B. anthracis\u2013specific DNA sequence from the culture isolate after only 3.5 hours. Although the nanopore-based assembly was error-prone when compared with the SRS-based assembly, as few as 8.5 hours would be required to find evidence of known AMR genes/markers or engineering, including gene insertions and extrachromosomal plasmids from B. anthracis. Although conventional AST remains essential for characterizing functional antimicrobial resistance in B. anthracis, nanopore sequencing provided same-day, onsite genomic characterization useful for an anthrax emergency response."
        ],
        "Acknowledgments": [
            "We thank scientists in the Zoonoses and Select Agent Laboratory, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), CDC, for performing shortread sequencing; scientists in the Antimicrobial Resistance and Characterization Laboratory, Division of Healthcare Quality Promotion, NCEZID, CDC, for performing conventional BMD AST; and scientists in the Biodefense Research and Development Laboratory, Division of Preparedness and Emerging Infections, NCEZID, CDC, for performing nanopore sequencing.",
            "This study was supported by the CDC Center for Preparedness and Response."
        ],
        "About the Author": [
            "Dr. McLaughlin is a scientist at the Biodefense Research and Development Laboratory, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Her primary research interests are development and evaluation of phenotypic and whole-genome sequencing\u2013based assays to characterize biological threat agents, with an emphasis on rapid detection of antimicrobial resistance in bacteria."
        ],
        "References": [
            "1. Carlson CJ, Kracalik IT, Ross N, Alexander KA, Hugh-Jones ME, Fegan M, et al The global distribution of Bacillus anthracis and associated anthrax risk to humans, livestock and wildlife. Nat Microbiol. 2019;4:1337\u201343. https://doi.org/10.1038/s41564-019-0435-4 2. Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, et al Workgroup on Anthrax Clinical Guidelines. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014; 20:e130687. https://doi.org/10.3201/eid2002.130687",
            "3. Price LB, Vogler A, Pearson T, Busch JD, Schupp JM, Keim P. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob Agents Chemother. 2003;47:2362\u20135. https://doi.org/10.1128/AAC.47.7.2362-2365.2003",
            "4. Pomerantsev AP, Shishkova NA, Marinin LI. Comparison of therapeutic effects of antibiotics of the tetracycline group in the treatment of anthrax caused by a strain inheriting tet-gene of plasmid pBC16 [in Russian]. Antibiot Khimioter. 1992;37:31\u20134.",
            "5. Ross CL, Thomason KS, Koehler TM. An extracytoplasmic function sigma factor controls beta-lactamase gene expression in Bacillus anthracis and other Bacillus cereus group species. J Bacteriol. 2009;191:6683\u201393. https://doi.org/ 10.1128/JB.00691-09",
            "6. Weigel LM, Sue D, Michel PA, Kitchel B, Pillai SP. A rapid antimicrobial susceptibility test for Bacillus anthracis. Antimicrob Agents Chemother. 2010;54:2793\u2013800. https://doi.org/10.1128/AAC.00247-10",
            "7. Gargis AS, McLaughlin HP, Conley AB, Lascols C, Michel PA, Gee JE, et al Analysis of whole-genome sequences for the prediction of penicillin resistance and \u03b2-lactamase activity in Bacillus anthracis. mSystems. 2018;3:e00154-18. https://doi.org/10.1128/mSystems.00154-18",
            "8. \u00c5gren J, Finn M, Bengtsson B, Segerman B. Microevolution during an anthrax outbreak leading to clonal heterogeneity and penicillin resistance. PLoS One. 2014;9:e89112. https://doi.org/10.1371/journal.pone.0089112",
            "9. Wick RR, Judd LM, Gorrie CL, Holt KE. Completing bacterial genome assemblies with multiplex MinION sequencing. Microb Genom. 2017;3:e000132. https://doi.org/ 10.1099/mgen.0.000132",
            "10. Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016;17:333\u201351. https://doi.org/10.1038/ nrg.2016.49",
            "11. Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, et al Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016;530:228\u201332. https://doi.org/10.1038/nature16996",
            "12. Greninger AL, Naccache SN, Federman S, Yu G, Mbala P, Bres V, et al Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med. 2015;7:99. https://doi.org/10.1186/s13073-015-0220-9",
            "13. Gargis AS, Cherney B, Conley AB, McLaughlin HP, Sue D. Rapid detection of genetic engineering, structural variation, and antimicrobial resistance markers in bacterial biothreat pathogens by nanopore sequencing. Sci Rep. 2019;9:13501. https://doi.org/10.1038/s41598-019-49700-1",
            "14. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disc susceptibility testing of infrequently isolated or fastidious bacteria, 3rd ed. M45. Wayne (PA): The Institute; 2016.",
            "15. Nouioui I, Klenk H-P, Igual JM, Gulvik CA, Lasker BA, McQuiston JR. Streptacidiphilus bronchialis sp. nov., a ciprofloxacin-resistant bacterium from a human clinical specimen; reclassification of Streptomyces griseoplanus as Streptacidiphilus griseoplanus comb. nov. and emended description of the genus Streptacidiphilus. Int J Syst Evol Microbiol. 2019;69:1047\u201356. https://doi.org/10.1099/ijsem.0.003267",
            "Address for correspondence: Heather P. McLaughlin, Centers for",
            "Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop",
            "H17-5, Atlanta, GA 30329-4027, USA; email: yfq4@cdc.gov"
        ]
    },
    "participants": [],
    "statistics": [],
    "keywords": [
        "B. anthracis",
        "short-read sequencing",
        "antimicrobial resistance",
        "public health emergency response",
        "genome assembly",
        "anthrax outbreak",
        "same day genomic characterization",
        "genomic characterization",
        "high containment laboratory",
        "genomic DNA",
        "broth microdilution",
        "Centers for Disease Control and Prevention",
        "antimicrobial resistance gene",
        "Bacillus anthracis",
        "Whole-genome sequencing",
        "genome sequencing",
        "biothreat pathogen",
        "human anthrax case",
        "rapid response",
        "antimicrobial susceptibility testing",
        "real time"
    ],
    "keyword_relevance": {
        "B. anthracis": 0.16521739130434782,
        "short-read sequencing": 0.1565217391304348,
        "antimicrobial resistance": 0.1565217391304348,
        "Bacillus anthracis": 0.08695652173913043,
        "Centers for Disease Control and Prevention": 0.0782608695652174,
        "Whole-genome sequencing": 0.06956521739130435,
        "broth microdilution": 0.05217391304347826,
        "genome sequencing": 0.043478260869565216,
        "genomic DNA": 0.034782608695652174,
        "antimicrobial susceptibility testing": 0.034782608695652174,
        "genome assembly": 0.02608695652173913,
        "genomic characterization": 0.02608695652173913,
        "anthrax outbreak": 0.017391304347826087,
        "biothreat pathogen": 0.017391304347826087,
        "public health emergency response": 0.008695652173913044,
        "antimicrobial resistance gene": 0.008695652173913044,
        "human anthrax case": 0.008695652173913044,
        "rapid response": 0.008695652173913044,
        "same day genomic characterization": 0.0,
        "high containment laboratory": 0.0,
        "real time": 0.0
    },
    "species": [
        "B. anthracis",
        "Bacillus anthracis"
    ],
    "summary": [
        "<h2 style=\"display: inline\">Introduction:</h2> Human anthrax cases necessitate rapid response.",
        "The authors completed Bacillus anthracis nanopore whole-genome sequencing in the high-containment laboratory from a human anthrax isolate hours after receipt.",
        "Same-day genomic characterization enhances public health emergency response.",
        "Anthracis as a bioweapon could pose an immediate risk to human populations.",
        "In such instances, a timely response is critical to reduce morbidity and mortality rates",
        "<h2 style=\"display: inline\">Conclusion:</h2> Real-time sequencing of the biothreat pathogen B. anthracis in a high-containment laboratory demonstrated the speed and usefulness of a rapid, portable<br/><br/>Table.",
        "Real-time sequencing of the biothreat pathogen B.",
        "Anthracis in a high-containment laboratory demonstrated the speed and usefulness of a rapid, portable.",
        "De novo whole-genome assembly metrics for sequencing of Bacillus anthracis strain Ba0914*.",
        "Nucleotide identity, %; average fold coverage Aligned to Mismatches Indels Contigs Chromosome pXO1 pXO2"
    ],
    "structured_summary": {
        "Introduction": [
            "Human anthrax cases necessitate rapid response.",
            "The authors completed Bacillus anthracis nanopore whole-genome sequencing in the high-containment laboratory from a human anthrax isolate hours after receipt.",
            "Same-day genomic characterization enhances public health emergency response.",
            "Anthracis as a bioweapon could pose an immediate risk to human populations.",
            "In such instances, a timely response is critical to reduce morbidity and mortality rates"
        ],
        "Conclusion": [
            "Real-time sequencing of the biothreat pathogen B. anthracis in a high-containment laboratory demonstrated the speed and usefulness of a rapid, portable<br/><br/>Table.",
            "Real-time sequencing of the biothreat pathogen B.",
            "Anthracis in a high-containment laboratory demonstrated the speed and usefulness of a rapid, portable.",
            "De novo whole-genome assembly metrics for sequencing of Bacillus anthracis strain Ba0914*.",
            "Nucleotide identity, %; average fold coverage Aligned to Mismatches Indels Contigs Chromosome pXO1 pXO2"
        ]
    },
    "reference_links": [
        {
            "id": "1",
            "alt_id": "Carlson_et+al_2019_a",
            "entry": "1. Carlson CJ, Kracalik IT, Ross N, Alexander KA, Hugh-Jones ME, Fegan M, et al. The global distribution of Bacillus anthracis and associated anthrax risk to humans, livestock and wildlife. Nat Microbiol. 2019;4:1337\u201343. https://doi.org/10.1038/s41564-019-0435-4",
            "crossref": "https://dx.doi.org/10.1038/s41564-019-0435-4",
            "scite": "https://scite.ai/reports/10.1038/s41564-019-0435-4",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1038/s41564-019-0435-4"
        },
        {
            "id": "2",
            "alt_id": "Hendricks_et+al_2014_a",
            "entry": "2. Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, et al. Workgroup on Anthrax Clinical Guidelines. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014; 20:e130687. https://doi.org/10.3201/eid2002.130687",
            "crossref": "https://dx.doi.org/10.3201/eid2002.130687",
            "scite": "https://scite.ai/reports/10.3201/eid2002.130687"
        },
        {
            "id": "3",
            "alt_id": "Price_et+al_2003_a",
            "entry": "3. Price LB, Vogler A, Pearson T, Busch JD, Schupp JM, Keim P. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob Agents Chemother. 2003;47:2362\u20135. https://doi.org/10.1128/AAC.47.7.2362-2365.2003",
            "crossref": "https://dx.doi.org/10.1128/AAC.47.7.2362-2365.2003",
            "scite": "https://scite.ai/reports/10.1128/AAC.47.7.2362-2365.2003",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1128/AAC.47.7.2362-2365.2003"
        },
        {
            "id": "4",
            "alt_id": "Pomerantsev_et+al_1992_a",
            "entry": "4. Pomerantsev AP, Shishkova NA, Marinin LI. Comparison of therapeutic effects of antibiotics of the tetracycline group in the treatment of anthrax caused by a strain inheriting tet-gene of plasmid pBC16 [in Russian]. Antibiot Khimioter. 1992;37:31\u20134.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Pomerantsev%2C%20A.P.%20Shishkova%2C%20N.A.%20Marinin%2C%20L.I.%20Comparison%20of%20therapeutic%20effects%20of%20antibiotics%20of%20the%20tetracycline%20group%20in%20the%20treatment%20of%20anthrax%20caused%20by%20a%20strain%20inheriting%20tet-gene%20of%20plasmid%20pBC16%201992"
        },
        {
            "id": "5",
            "alt_id": "Ross_et+al_2009_a",
            "entry": "5. Ross CL, Thomason KS, Koehler TM. An extracytoplasmic function sigma factor controls beta-lactamase gene expression in Bacillus anthracis and other Bacillus cereus group species. J Bacteriol. 2009;191:6683\u201393. https://doi.org/10.1128/JB.00691-09",
            "crossref": "https://dx.doi.org/10.1128/JB.00691-09",
            "scite": "https://scite.ai/reports/10.1128/JB.00691-09",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1128/JB.00691-09"
        },
        {
            "id": "6",
            "alt_id": "Weigel_et+al_2010_a",
            "entry": "6. Weigel LM, Sue D, Michel PA, Kitchel B, Pillai SP. A rapid antimicrobial susceptibility test for Bacillus anthracis. Antimicrob Agents Chemother. 2010;54:2793\u2013800. https://doi.org/10.1128/AAC.00247-10",
            "crossref": "https://dx.doi.org/10.1128/AAC.00247-10",
            "scite": "https://scite.ai/reports/10.1128/AAC.00247-10",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1128/AAC.00247-10"
        },
        {
            "id": "7",
            "alt_id": "Gargis_et+al_2018_a",
            "entry": "7. Gargis AS, McLaughlin HP, Conley AB, Lascols C, Michel PA, Gee JE, et al. Analysis of whole-genome sequences for the prediction of penicillin resistance and \u03b2-lactamase activity in Bacillus anthracis. mSystems. 2018;3:e00154-18. https://doi.org/10.1128/mSystems.00154-18",
            "crossref": "https://dx.doi.org/10.1128/mSystems.00154-18",
            "scite": "https://scite.ai/reports/10.1128/mSystems.00154-18"
        },
        {
            "id": "8",
            "alt_id": "\u00c5gren_et+al_2014_a",
            "entry": "8. \u00c5gren J, Finn M, Bengtsson B, Segerman B. Microevolution during an anthrax outbreak leading to clonal heterogeneity and penicillin resistance. PLoS One. 2014;9:e89112. https://doi.org/10.1371/journal.pone.0089112",
            "crossref": "https://dx.doi.org/10.1371/journal.pone.0089112",
            "scite": "https://scite.ai/reports/10.1371/journal.pone.0089112",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1371/journal.pone.0089112"
        },
        {
            "id": "9",
            "alt_id": "Wick_et+al_2017_a",
            "entry": "9. Wick RR, Judd LM, Gorrie CL, Holt KE. Completing bacterial genome assemblies with multiplex MinION sequencing. Microb Genom. 2017;3:e000132. https://doi.org/10.1099/mgen.0.000132",
            "crossref": "https://dx.doi.org/10.1099/mgen.0.000132",
            "scite": "https://scite.ai/reports/10.1099/mgen.0.000132",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1099/mgen.0.000132"
        },
        {
            "id": "10",
            "alt_id": "Goodwin_et+al_2016_a",
            "entry": "10. Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016;17:333\u201351. https://doi.org/10.1038/nrg.2016.49",
            "crossref": "https://dx.doi.org/10.1038/nrg.2016.49",
            "scite": "https://scite.ai/reports/10.1038/nrg.2016.49",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1038/nrg.2016.49"
        },
        {
            "id": "11",
            "alt_id": "Quick_et+al_2016_a",
            "entry": "11. Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016;530:228\u201332. https://doi.org/10.1038/nature16996",
            "crossref": "https://dx.doi.org/10.1038/nature16996",
            "scite": "https://scite.ai/reports/10.1038/nature16996",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1038/nature16996"
        },
        {
            "id": "12",
            "alt_id": "Greninger_et+al_2015_a",
            "entry": "12. Greninger AL, Naccache SN, Federman S, Yu G, Mbala P, Bres V, et al. Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med. 2015;7:99. https://doi.org/10.1186/s13073-015-0220-9",
            "crossref": "https://dx.doi.org/10.1186/s13073-015-0220-9",
            "scite": "https://scite.ai/reports/10.1186/s13073-015-0220-9",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1186/s13073-015-0220-9"
        },
        {
            "id": "13",
            "alt_id": "Gargis_et+al_2019_a",
            "entry": "13. Gargis AS, Cherney B, Conley AB, McLaughlin HP, Sue D. Rapid detection of genetic engineering, structural variation, and antimicrobial resistance markers in bacterial biothreat pathogens by nanopore sequencing. Sci Rep. 2019;9:13501. https://doi.org/10.1038/s41598-019-49700-1",
            "crossref": "https://dx.doi.org/10.1038/s41598-019-49700-1",
            "scite": "https://scite.ai/reports/10.1038/s41598-019-49700-1",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1038/s41598-019-49700-1"
        },
        {
            "id": "14",
            "alt_id": "14._2016_a",
            "entry": "14. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disc susceptibility testing of infrequently isolated or fastidious bacteria, 3rd ed. M45. Wayne (PA): The Institute; 2016.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Clinical%20and%20Laboratory%20Standards%20Institute%20Methods%20for%20antimicrobial%20dilution%20and%20disc%20susceptibility%20testing%20of%20infrequently%20isolated%20or%20fastidious%20bacteria%203rd%20ed%20M45%20Wayne%20PA%20The%20Institute%202016"
        },
        {
            "id": "15",
            "alt_id": "Nouioui_et+al_2019_a",
            "entry": "15. Nouioui I, Klenk H-P, Igual JM, Gulvik CA, Lasker BA, McQuiston JR. Streptacidiphilus bronchialis sp. nov., a ciprofloxacin-resistant bacterium from a human clinical specimen; reclassification of Streptomyces griseoplanus as Streptacidiphilus griseoplanus comb. nov. and emended description of the genus Streptacidiphilus. Int J Syst Evol Microbiol. 2019;69:1047\u201356. https://doi.org/10.1099/ijsem.0.003267 ",
            "crossref": "https://dx.doi.org/10.1099/ijsem.0.003267",
            "scite": "https://scite.ai/reports/10.1099/ijsem.0.003267",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1099/ijsem.0.003267"
        }
    ],
    "facts": [
        "completed Bacillus anthracis nanopore whole-genome sequencing in our high-containment laboratory",
        "novo assembled genome showed no evidence of known antimicrobial resistance genes",
        "Deliberate misuse of B. anthracis as a bioweapon could pose an immediate risk to human populations",
        "Anthracis as a bioweapon could pose an immediate risk to human populations",
        "average fold coverage Aligned to Mismatches Indels Contigs Chromosome pXO1 pXO2",
        "that strain Ba0914 was susceptible to ciprofloxacin"
    ],
    "claims": [
        "This study describes the laboratory work and demonstrates the usefulness of rapid WGS to inform time-sensitive public health responses",
        "By using the conventional BMD method, we found that strain Ba0914 was susceptible to ciprofloxacin, levofloxacin, tetracycline, doxycycline, penicillin, and amoxicillin"
    ],
    "findings": [],
    "processes": [],
    "key_statements": [
        "This study describes the laboratory work and demonstrates the usefulness of rapid Whole-genome sequencing to inform time-sensitive public health responses",
        "By using the conventional broth microdilution method, we found that strain Ba0914 was susceptible to ciprofloxacin, levofloxacin, tetracycline, doxycycline, penicillin, and amoxicillin"
    ],
    "top_statements": [
        "This study describes the laboratory work and demonstrates the usefulness of rapid Whole-genome sequencing to inform time-sensitive public health responses",
        "By using the conventional broth microdilution method, we found that strain Ba0914 was susceptible to ciprofloxacin, levofloxacin, tetracycline, doxycycline, penicillin, and amoxicillin"
    ],
    "headline": "By using the conventional broth microdilution method, we found that strain Ba0914 was susceptible to ciprofloxacin, levofloxacin, tetracycline, doxycycline, penicillin, and amoxicillin",
    "contexts": [],
    "abbreviations": {
        "CDC": "Centers for Disease Control and Prevention",
        "AST": "antimicrobial susceptibility testing",
        "BMD": "broth microdilution",
        "AMR": "antimicrobial resistance",
        "WGS": "Whole-genome sequencing",
        "SRS": "short-read sequencing",
        "gDNA": "genomic DNA"
    }
}
